Tag: senility

Jill Biden Laughs About Covering for Joe Biden’s Cognitive Decline 

Dr. Jill laughed about covering for Joe Biden’s cognitive decline during her latest interview amid her tour for her book, “View from the East Wing.”

Jill Biden continued to make the media rounds on Monday and sat down with Craig Melvin on the TODAY show to discuss life after the White House and Joe Biden’s cognitive decline.

Dr. Jill shocked the public when she recently claimed that she thought Joe Biden had a stroke during the 2024 presidential debate.

TODAY show host Craig Melvin asked Jill Biden about the moments after Biden finished the debate.

“I wanna say the things that are true, and so I said ‘you answered every question,’” Jill Biden explained.

“That’s a pretty low bar,” Craig Melvin said.

“Well…haha,” Jill Biden said, laughing.

“My mind is racing. What do I say to him? What do I say to him?” Jill Biden said about her husband’s disastrous debate. “I’m his wife. I’ve got to lift him up.

“I’m not going to get out there on the stage and say, ‘Joe, you really screwed that up,’” Jill Biden said.

She continued, “And we have all our supporters there. That’s who we are. I had to support him. I couldn’t come out and really publicly say, ‘Joe, you did a terrible job in that debate.’”

Keep reading

Dr. Jill Repeatedly Claims She Never Saw Signs that Joe Biden Was Falling Into Cognitive Decline – And CBS Mornings Host Isn’t Even Buying It

Dr. Jill insisted that she had never seen anything to indicate that Joe Biden was in cognitive decline during an interview with CBS Mornings host Rita Braver.

Jill Biden sat down for an interview with CBS Mornings to discuss life after the White House.

“Did you ever see signs that [Biden] was falling into cognitive decline?” Rita Braver asked Jill Biden.

“No,” Jill Biden said.

Rita Braver was not buying Jill Biden’s claim.

“No?” Rita Braver asked.

“No,” Jill Biden insisted.

“Truly?” Rita Braver asked.

“No,” Jill Biden said.

“Oh, he was definitely aging; I mean, we were all aging,” Jill added. “So, yes, he was slowing down.”

“People were saying he wasn’t the same Joe Biden,” Rita Braver said.

“Well, I don’t think that’s true,” Jill said.

She continued, “He was the same, the essence of the same Joe Biden, but yeah, he was slowing down. He was getting older.”

“It’s a very intense job. I think it ages you quickly. Look at the other presidents, I mean, in comparison, when they started in office and got out of office. It was natural aging,” Jill Biden insisted.

Keep reading

“She’s Lying” – Former Biden Official Reacts to Jill Biden’s Claims She “Never” Saw Joe Biden Stroke Out Before Or After the 2024 Debate

A former Biden official reacted to Jill Biden’s interview with CBS Mornings in which she claimed she thought Joe Biden had a stroke during the 2024 debate.

Dr. Jill told CBS Mornings host Rita Braver that she thought Joe Biden was having a stroke during the 2024 presidential debate.

Jill Biden insisted she never saw Joe Biden stroke out like this before or after the June 2024 debate.

“I was frightened, because I had never ever seen Joe like that before or since. Never since,” Jill Biden told CBS News Sunday Morning’s Rita Braver.

“I don’t know what happened. As I watched it, I thought, ‘Oh, my God, he’s having a stroke.’ And it scared me to death,” Jill Biden added.

A day after the debate, Jill Biden got on stage and praised Joe for answering all the questions perfectly.

Keep reading

Judge Grants Biden’s Request to Intervene in FOIA Fight, Blocks Public Release of 70 Hours of Audiotapes of His Conversations with Ghostwriter

A federal judge on Thursday granted Joe Biden’s request to block the public release of the audiotapes of his conversations with his ghostwriter.

The Oversight Project filed a FOIA lawsuit requesting records from Special Counsel Robert Hur’s investigation into Biden. The judge denied the Oversight Project’s request.

However, US District Judge Dabney Friedrich, a Trump appointee, denied Biden’s request to use this case to block the release of the audiotapes to the House Judiciary Committee.

Earlier this month, it was reported that the DOJ was preparing to release damning audio of Biden’s interview with former Special Counsel Robert Hur. The Department is also going to release 2017 audio recordings of conversations with his ghostwriter in which he disclosed classified information.

Biden previously asserted executive privilege over the audio recordings related to then-Special Counsel Robert Hur’s investigation into his stolen classified documents scandal.

Republicans have argued that Joe Biden cannot assert executive privilege over the audio since the transcript has already been released.

Then-US Attorney General Merrick Garland classified the audio tapes of Biden’s interview with Hur as “Top Secret” and locked it way in a SCIF.

Keep reading

Awkward moment an aging Mitch McConnell needs help from staff during hearing with Pete Hegseth

Mitch McConnell appeared confused when a staffer interrupted him because he tried to end a Senate hearing with Pete Hegseth before it was set to conclude.

The former Majority Leader, 84, was part of a hearing of the Senate Committee on Appropriations on Defense that had been questioning the defense secretary regarding the War in Iran. 

As McConnell was given the floor again after questioning by Alaska Republican Lisa Murkowski, he tried to end the hearing with Hegseth, much to his colleagues’ confusion.

‘Here’s where we are, the vote is about over, the secretary has to get with the President on the China trip, I’m gonna’ ask Senator Murkowski to wrap up and thank you all for being here.’

Before finishing, he was interrupted by a younger, male staffer who could be heard whispering into his ear. 

‘Baldwin, Shaheen, and Kennedy still have questions,’ the staffer said.

He was referring to Wisconsin Democrat Senator Tammy Baldwin, New Hampshire Democrat Jeanne Shaheen and Republican John Kennedy. 

The staffer can then be heard clarifying that the hearing should ‘wrap up after’ those questions. 

Keep reading

Alzheimer’s Drugs Have No ‘Meaningful Effect’ on Cognitive Decline: Review

A class of Alzheimer’s drugs that have only been available for several years did not appear to have any “clinically meaningful effects,” according to a new review of clinical trial data.

Monoclonal antibodies that target plaque called amyloid beta in the brain showed little impact across 17 trials, Francesco Nonino, a neurologist and epidemiologist who directs the Unit of Epidemiology and Statistics at the IRCCS Institute of Neurological Sciences of Bologna, Italy, and co-authors wrote in the review.

“The effect of amyloid‐beta‐targeting monoclonal antibodies on cognitive function and dementia severity at 18 months in people with mild cognitive impairment or mild dementia due to Alzheimer’s disease is trivial, while on functional ability, it is small at best,” they said.

“Successful removal of amyloid from the brain does not seem to be associated with clinically meaningful effects in people with mild cognitive impairment or mild dementia due to Alzheimer’s disease. Future research on disease‐modifying treatments for Alzheimer’s disease should focus on other mechanisms of action,” they added later.

The review covered 17 studies involving 20,342 participants. The drugs were typically compared with placebos in the trials, which were all funded by pharmaceutical companies.

The monoclonal antibodies in question were first approved by the U.S. Food and Drug Administration in 2021. They include Lecanemab, which is available in the United States and other countries and is produced by Eisai and Biogen, and Eli Lilly’s Donanemab.

Keep reading

LAUGHABLE: Rep. Jamie Raskin Who Repeatedly Defended Joe Biden’s Mind of Mush is Now Demanding a Cognitive Assessment of President Trump

Rep. Jamie Raskin and other House Democrats are demanding that the White House perform a cognitive assessment of President Trump and publish the results.

Republicans, members of the Trump administration, and the general public should point and laugh at these people. Ridicule them harshly until they wander away in defeat.

These are the same people who not only defended Joe Biden for four years, but smeared anyone who dared to question Biden’s obvious issues of mental acuity.

The Hill reported:

Raskin asks White House physician for ‘comprehensive cognitive assessment’ of Trump

Rep. Jamie Raskin (D-Md.) on Friday pressed the White House physician for a full evaluation of President Trump’s cognitive abilities.

In a letter to Sean Barbabella, a Navy captain serving as Trump’s official doctor, Raskin argued that Trump’s words and actions in recent months — particularly those surrounding the Iran war — have raised enough questions about the president’s mental acuity to merit a “comprehensive cognitive assessment.” Raskin wants the results shared publicly.

“Experts have repeatedly warned that the President has been exhibiting signs consistent with dementia and cognitive decline. And, in recent days, the country has watched President Trump’s public statements and outbursts turn increasingly incoherent, volatile, profane, deranged, and threatening,” wrote Raskin, the senior Democrat on the House Judiciary Committee.

“His apparently deteriorating condition has caused tremendous alarm across the nation (and political spectrum) about the President’s cognitive function and continuing mental fitness for the office of President, and prompted concerns about the President’s wellbeing.”

These people have no shame whatsoever.

Keep reading

While Pushing New Book, Jill Biden Claims Joe Biden Made the ‘Unprecedented Decision’ Not to Seek Reelection in 2024

Former First Lady Jill Biden is releasing a new book about her time in the White House because of course she is. What else are she and Joe going to do for money other than write books and go on book tours?

In a video she released on social media, she claims that it was Joe who made the unprecedented decision to not seek reelection in 2024. That seems like a bit of historical revisionism.

Actor George Clooney wrote an op-ed for the NY Times demanding that Joe Drop out of the race and many people suspect that Obama played a role in the writing of the piece. Joe only dropped out of the race when Democrat donors made it clear that they would not donate another dime as long as Biden was the nominee. Chuck Schumer had private meetings with Biden and so did Nancy Pelosi.

But it was Joe Biden’s decision to drop out? OK.

Keep reading

Grab the Popcorn: Trump Executive Privilege Decision Means All That Info on Biden Is Coming Out

President Donald Trump just made a big decision that will likely expose a lot of information that was not released about Joe Biden during his occupation of the Oval Office. 

Trump has rejected Biden’s claim of executive privilege to not turn over documents requested in various Senate probes, determining it is “not in the best interests of the United States.” 

White House counsel David Warrington wrote Monday in a letter addressed to the National Archives and Records Administration (NARA) and obtained by Fox News Digital that Trump “does not uphold the former President’s assertion of privilege” over records sought in four congressional probes. The letter directs NARA to provide the materials to Congress.

The dispute centers on documents related to investigations into Biden’s health, alleged politically motivated probes into Trump and his allies, and the Biden family’s financial dealings, which Republicans argue go to the heart of Congress’s constitutional authority to conduct oversight.

That means that the White House is telling NARA to turn over anything about the “cover-up” of “Biden’s health and cognitive decline.” Imagine all the potential documents that could involve — we could see all the machinations and who specifically did what regarding any concealing of his cognitive decline. 

“The abuse of the autopen that took place during the Biden Presidency, and the extraordinary efforts to shield President Biden’s diminished faculties from the public, must be subject to a full accounting to ensure nothing similar ever happens again,” Warrington wrote, quoting a prior letter.

Warrington had previously weighed in when Trump denied the executive privilege regarding the autopen issue. 

Keep reading

Study: Lifetime Cannabis Use Not Associated With Cognitive Decline or Dementia Risk in Older Adults

Cannabis use by older adults is not associated with either accelerated cognitive decline or greater risk of dementia, according to findings published in the journal BMJ Mental Health.

Investigators affiliated with Yale University and the University of Oxford in the United Kingdom assessed cognitive performance in lifetime cannabis consumers and non-users across various domains — including memory, intelligence, and problem solving. Data was drawn from two large nationally representative cohorts (the UK Biobank and the US Million Veteran Program), consisting of several hundred thousand participants.

Researchers reported that those with a history of cannabis use “demonstrated significantly better cognitive performance,” a finding that is consistent with prior studies. Cannabis use “was not associated with increased risk of dementia” and researchers found “no supporting evidence of a causal link with [longitudinal] cognitive decline in later life.”

The study’s authors concluded: “This study represents one of the largest observational investigations to date examining the relationship between cannabis use, cognitive function and dementia risk in older adults. … Our findings are broadly consistent with prior population-based longitudinal studies that have not observed accelerated age-related cognitive decline associated with cannabis use. … Clinicians can consider that occasional or prior cannabis use may not be a major contributor to cognitive aging in this population.”

Commenting on the findings, NORML’s Deputy Director Paul Armentano said: “These results contradict one of the more prominent and longstanding stereotypes about cannabis and cannabis consumers. It is unfortunate that these stereotypes often go unchallenged in the media and elsewhere. It is even more unfortunate that studies refuting these long-held stereotypes seldom receive the type of mainstream attention they deserve.”

Several other recent studies have reported similar results. For example, an Israeli study of over 67,000 older adults reported that participants with a history of cannabis use “performed better across all cognitive domains: attention, executive function, processing speed, visual and working memory. … Additionally, past use was associated with a slower decline in executive function.”

A Danish study similarly concluded that cannabis consumers experienced “significantly less cognitive decline” over their lifetimes than did non-users.

Most recently, a study published in January in the Journal of Studies on Alcohol and Drugs concluded: “Greater lifetime [cannabis] use was also associated with better performance on cognitive tasks assessing learning, memory, processing speed, and task switching, aligning with growing evidence of potential neuroprotective effects of cannabis in aging populations. … This study adds to a growing body of evidence that cannabis use may be associated with greater brain volume and cognitive performance in aging adults, especially in regions rich in cannabinoid receptors.”

Keep reading